Insmed (INSM) Invested Capital (2011 - 2025)
Insmed (INSM) posted quarterly Invested Capital of $24.1 million for Q4 2025, down 10.96% year-over-year from $27.0 million in Q4 2024, and down 10.96% quarter-over-quarter from $27.0 million in Q4 2024.
Insmed (INSM) Invested Capital (2011 - 2025) Analysis & Trends
Insmed's Invested Capital history runs 13 years deep, the most recent figure standing at $24.1 million for Q4 2025.
- In Q4 2025, Invested Capital fell 10.96% year-over-year to $24.1 million; the TTM figure through Mar 2026 stood at $24.1 million (down 90.43% YoY), while the FY2025 annual figure was $24.1 million, down 10.96% from the prior year.
- Invested Capital for Q4 2025 stood at $24.1 million, down from $27.0 million in the prior quarter.
- The five-year high for Invested Capital was $224.4 million in Q2 2024, with the low at $14.7 million in Q4 2021.
- The 5-year median for Invested Capital is $29.6 million (2023), against an average of $82.1 million.
- The sharpest annual moves came in 2022 and 2025: Invested Capital surged 109.71% in 2022, then declined 10.96% in 2025.
- Insmed's Invested Capital stood at $14.7 million in 2021, then jumped by 109.71% to $30.9 million in 2022, then dropped by 3.94% to $29.6 million in 2023, then declined by 8.81% to $27.0 million in 2024, then dropped by 10.96% to $24.1 million in 2025.
- Business Quant data shows INSM's Invested Capital at $24.1 million in Q4 2025, $27.0 million in Q4 2024, and $224.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.06 Mn |
| Dec 31, 2024 | 27.03 Mn |
| Jun 30, 2024 | 224.45 Mn |
| Mar 31, 2024 | 224.19 Mn |
| Dec 31, 2023 | 29.64 Mn |
| Dec 31, 2022 | 30.85 Mn |
| Dec 31, 2021 | 14.71 Mn |
| Dec 31, 2020 | 15.79 Mn |
| Dec 31, 2019 | 20.75 Mn |
| Jun 30, 2016 | 8.69 Mn |
| Mar 31, 2016 | 5.67 Mn |
| Dec 31, 2015 | 3.11 Mn |
| Sep 30, 2015 | 25.26 Mn |
| Jun 30, 2015 | 25.12 Mn |
| Mar 31, 2015 | 24.99 Mn |
| Sep 30, 2014 | 5.18 Mn |
| Jun 30, 2014 | 3.28 Mn |
| Mar 31, 2014 | 5.19 Mn |
| Dec 31, 2013 | 100,000.00 |
| Sep 30, 2013 | -7.06 Mn |